Introducing our first product ze-ets-001
Gamgee was founded by Paul Conyngham after he designed a personalised mRNA cancer vaccine for his dog Rosie. Now, we’re bringing that hope to more dogs with cancer.
Currently running clinical trials in Australia and inviting registrations of interest worldwide.
If selected, GAMGEE manages the entire process end to end.
We review the details you share and reach out to discuss your dog's case. If there's a fit, we move forward together.
We work with your vet to confirm the diagnosis, collect a tissue sample, and send it to our genomics lab.
We analyse the data, identify the mutations driving the cancer, and design a personalised protocol.
Your dog receives their personalised treatment from a veterinary oncologist. We monitor response.

In 2024, my dog Rosie was diagnosed with mast cell cancer. We tried surgery, chemotherapy, immunotherapy. Nothing worked. The vets gave her months to live. One breakthrough treatment later, two more years were added to Rosie's life.
Read Rosie's mRNA cancer vaccine story →
Get occasional updates on our research, clinical trials and progress in personalised cancer care for dogs.
We'll help you determine whether GAMGEE is right for your dog and, if it is, get you connected with the right team.
Register your interest